Sign in
Taking people in United StatesNo phase

Collects samples from adults with cancer or pre-cancer to study why treatments work differently

Collects tissue and blood samples from adults with several cancers.

Key facts

Who runs it
National Cancer Institute (NCI)
Where
Bethesda, United StatesSee the site
Trial code
Registry title
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Status
Recruiting
People taking part
500 people, planned
Started
11 Apr 2016
Expected to end
1 Dec 2032
Type of study
Observational
Record updated
12 November 2026

Who can take part

Age
18 years to 120 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who cannot take part

  • Active concomitant medical or psychological illnesses that may increase the risk to the subject
  • Inability to provide informed consent
  • Pregnant or breastfeeding women

Other criteria

  • INCLUSION CRITERIA:; Diagnosis of cancer, a premalignant/neoplastic condition or disease (such as an immunodeficiency) that increases the risk of being diagnosed with a cancer or premalignant/neoplastic condition; Age >=18 years of age; ECOG performance status of 0-3; Ability and willingness of subject to provide informed consent; Additional inclusion criteria pertinent only for participants undergoing apheresis
  • Hemoglobin >= 8 mg/dL and platelet count > 75 K/microL
  • Weight >= 48 kg
  • Central line in place or adequate venous access

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 120 years old?

Where in United States

  • National Institutes of Health Clinical CenterBethesda, United StatesContact: Scott M Norberg, D.O.Taking people

About the trial

What the trial wants to find out

Background:

Read full original descriptionShow less

Cancer has a major impact in the United States and across the world. In 2015, over 1.5 million new cases of cancer were diagnosed in the U.S. Researchers want to study samples from people with cancer or a pre-malignant condition. They hope to develop more effective treatments.

Objective:

To better understand the biology of malignancies and why certain cancers respond differently to treatment.

Eligibility:

Adults at least 18 years old with cancer or a pre-cancerous condition.

Design:

Participants will be screened with a medical history, physical exam, and blood tests. Their diagnosis will be confirmed by the NCI Laboratory of Pathology.

Participants will send tissue blocks or slides from their original tumor biopsy.

At least once, participants will have a medical history, physical exam, and blood and urine tests.

Participants may have the following tests. They may have them more than once:

Apheresis. A needle in one arm removes blood. Blood is run through a machine and the sample cells are taken out. The rest of the blood is returned by a needle in the other arm.

Bone marrow aspiration and biopsy. The hipbone will be numbed. A needle will be put into the hipbone. Bone marrow will be taken out through the needle.

Piece of cancer tissue taken by a needle and syringe.

Computed tomography (CT) scan, magnetic resonance imaging (MRI) and/or positron emission tomography (PET) scan or ultrasound to help locate their tumor. For the scans, they lie in a machine that takes pictures.

A small piece of skin removed.

Participants will be contacted by phone once a year to find out how they are doing.

...

The group in the trial

  • 1/Cohort 1

    Patients with cancer or a premalignant condition or at risk of cancer from an immunodeficiency

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Plain-language title
Collects samples from adults with cancer or pre-cancer to study why treatments work differentlyGenerated from the registry record. The registry title is the official one.
Fit questions
Built from NCT02682667, who can take part
Record updated
12 November 2026